πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 14,889 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 6566324

Preventing airway mucus production by administration of EGF-R antagonists

The Regents of the University of California Β· Granted Tue May 20 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6566326

Chemically modified hemoglobin for burn shock resuscitation

The Regents of the University of California Β· Granted Tue May 20 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6566342

Gene therapy by secretory gland expression

The Regents of the University of California Β· Granted Tue May 20 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6566500

Compositions and methods for modifying toxic effects of proteinaceous compounds

The Board of Regents of the University of Texas System Β· Granted Tue May 20 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6566509

Multivalent macrolide antibiotics

Theravance, Inc. Β· Granted Tue May 20 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6565827

Radioimmunotherapy of lymphoma using anti-CD20 antibodies

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue May 20 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6565831

Methods for preventing reovirus recognition for the treatment of cellular proliferative di

ONCOLYTICS BIOTECH INC. Β· Granted Tue May 20 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6562606

Methods and compositions for disrupting the epithelial barrier function

The Regents of the University of California Β· Granted Tue May 13 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 08 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6562819

Compounds for inhibition of ceramide-mediated signal transduction

The Regents of the University of California Β· Granted Tue May 13 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 08 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6562859

Ureido derivatives of poly-4-amino-2-carboxy-1-methyl pyrrole compounds for inhibition of

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 13 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 08 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6562861

Substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors

BioCryst Pharmaceuticals, Inc. Β· Granted Tue May 13 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 08 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6562942

Methods for treatment of diabetes using peptide analogues of insulin

Neurocrine Biosciences, Inc. Β· Granted Tue May 13 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 08 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6562347

Chemokine-tumor antigen fusion proteins as cancer vaccines

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 13 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 08 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6559282

Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens i

United Biomedical, Inc. Β· Granted Tue May 06 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 01 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6558668

Methods for detection and treatment of neural cancers

The Regents of the University of California Β· Granted Tue May 06 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 01 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6558659

Stable pharmaceutical compositions containing 7-substituted-3,5-dihydroxyheptanoic acids o

TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Tue May 06 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 01 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6558688

Ocular tissue regeneration inducer

KURARAY CO., LTD. Β· Granted Tue May 06 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 01 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6558698

Microencapsulated bioactive agents and method of making

The United States of America as represented by the Administrator of the National Aeronautics and Space Administration Β· Granted Tue May 06 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 01 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6559121

Vaccines for the protection of cattle from psoroptic scabies

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue May 06 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 01 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6559189

Non-toxic antimicrobial compositions and methods of use

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue May 06 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 01 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6555116

Alleviation of the allergenic potential of airborne and contact allergens by thioredoxin

The Regents of the University of California Β· Granted Tue Apr 29 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6555127

Multi-spike release formulation for oral drug delivery

Pharmaceutical Discovery Corporation Β· Granted Tue Apr 29 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6555145

Alternate encapsulation process and products produced therefrom

Capricorn Pharma Inc. Β· Granted Tue Apr 29 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6555367

Complex of biotinylated viral vector and ligand for targeted gene delivery

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Apr 29 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired